Frequently Asked Questions
COVID-19 pandemic had a substantial impact on the healthcare sector. The in-vitro colorectal cancer screening market was also affected owing to the pandemic. Restrictions imposed by the government, a lower number of patients visiting hospitals & clinics, and an increasing focus on doctors for screening COVID-19 patients were some factors affecting the market
North America accounted for the largest share of the global In-vitro colorectal cancer screening market.
What are the key drivers for the growth of the in-vitro colorectal cancer screening market?
The growing prevalence of colorectal cancer and the rising need for testing for cancer diagnosis are the key drivers of the in-vitro colorectal cancer screening market growth.
The fecal occult blood tests segment had a major share in the global market in 2021.
The colonoscopy segment had a major share in the global market.